{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:18:24Z","timestamp":1791299904135,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In the ischemic penumbra, necroptosis-induced inflammation exacerbates neurovascular unit (NVU) injury, though neuronal self-regulatory mechanisms are poorly understood. This study examined whether the PARK7\u2013Nrf2 axis, a key antioxidant pathway, alleviates NLRP3-driven inflammation during necroptosis to protect the NVU.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study integrated a rat middle cerebral artery occlusion\/reperfusion (MCAO\/R) model in vivo and an in vitro model of primary cortical neuronal necroptosis induced by oxygen-glucose deprivation\/reoxygenation (OGD\/R) combined with the pan-caspase inhibitor Q-VD-Oph. Lentivirus-mediated gene knockdown and overexpression, pharmacological interventions including specific inhibitors (Nec-1), activators (tBHQ), and the protein translation inhibitor CHX were employed. These were combined with molecular biology techniques such as Western blot, immunofluorescence, co-immunoprecipitation, and RT-qPCR to systematically dissect the role and regulatory mechanisms of PARK7.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hypoxia\/reoxygenation injury robustly activated neuronal necroptosis, which subsequently triggered the assembly and activation of the NLRP3 inflammasome, leading to NVU disruption. Notably, PARK7 expression was significantly upregulated post-hypoxia\/reoxygenation. Mechanistically, PARK7 directly enhanced Nrf2 activation through a dual mechanism: facilitating the dissociation of Nrf2 from Keap1 and promoting its nuclear translocation, while simultaneously stabilizing the Nrf2 protein and reducing its degradation. Activated Nrf2 subsequently upregulated the expression of downstream antioxidant proteins NQO1 and HO-1. This PARK7-Nrf2 signaling axis effectively suppressed the NLRP3 inflammasome and its associated inflammatory cascade. Consequently, PARK7 overexpression significantly alleviated NVU damage, reduced cerebral infarct volume, and improved neurological function, whereas PARK7 knockdown exacerbated these injuries. The detrimental effects caused by PARK7 deficiency were reversed by the Nrf2 activator tBHQ.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reveals that PARK7 activates the Nrf2\/ARE pathway, via promoting Nrf2-Keap1 dissociation and stabilizing Nrf2, to inhibit necroptosis-driven NLRP3 inflammasome overactivation in the ischemic penumbra. This mechanism provides a novel regulatory pathway for inflammation and highlights the PARK7\/Nrf2 axis as a therapeutic target to mitigate neurovascular unit injury, thereby extending the treatment window and enabling a combined recanalization-cytoprotection strategy with significant translational promise.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-07898-5","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T04:33:23Z","timestamp":1771994003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PARK7-Nrf2 axis mitigates NLRP3-driven inflammation to rescue neurovascular unit from hypoxia\/reoxygenation-induced necroptosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhiyuan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meifang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7694-2684","authenticated-orcid":false,"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"issue":"14","key":"7898_CR1","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1093\/eurheartj\/ehad865","volume":"45","author":"G Stoll","year":"2024","unstructured":"Stoll G, Schuhmann M K, Kollikowski A M, et al. New mechanisms-based therapies in acute ischaemic stroke. Eur Heart J. 2024;45(14):1190\u201392.","journal-title":"Eur Heart J"},{"issue":"3","key":"7898_CR2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/0271678X211032029","volume":"42","author":"JL Fan","year":"2022","unstructured":"Fan JL, Brassard P, Rickards C A, et al. Integrative cerebral blood flow regulation in ischemic stroke. J Cereb Blood Flow Metab. 2022;42(3):387\u2013403.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"10446","key":"7898_CR3","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1016\/S0140-6736(24)00642-1","volume":"403","author":"NA Hilkens","year":"2024","unstructured":"Hilkens NA, Casolla B, Leung T W, et al. Stroke. Lancet. 2024;403(10446):2820\u201336.","journal-title":"Lancet"},{"issue":"8","key":"7898_CR4","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s12276-023-01078-x","volume":"55","author":"W Park","year":"2023","unstructured":"Park W, Wei S, Kim B S, et al. Diversity and complexity of cell death: a historical review. Exp Mol Med. 2023;55(8):1573\u201394.","journal-title":"Exp Mol Med"},{"issue":"7","key":"7898_CR5","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1007\/s12035-023-03728-7","volume":"61","author":"Q Wang","year":"2024","unstructured":"Wang Q, Yang F, Duo K, et al. The role of necroptosis in cerebral ischemic stroke. Mol Neurobiol. 2024;61(7):3882\u201398.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"7898_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/med.21817","volume":"42","author":"QZ Tuo","year":"2022","unstructured":"Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev. 2022;42(1):259\u2013305.","journal-title":"Med Res Rev"},{"issue":"8","key":"7898_CR7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.it.2023.05.007","volume":"44","author":"J Huyghe","year":"2023","unstructured":"Huyghe J, Priem D, Bertrand M. Cell death checkpoints in the TNF pathway. Trends Immunol. 2023;44(8):628\u201343.","journal-title":"Trends Immunol"},{"issue":"7","key":"7898_CR8","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1093\/brain\/awad045","volume":"146","author":"P Chen","year":"2023","unstructured":"Chen P, Yen J, Liu T, et al. Neuronal NLRP3 inflammasome mediates spreading depolarization- evoked trigeminovascular activation. Brain: J Neurol. 2023;146(7):2989\u20133002.","journal-title":"Brain: J Neurol"},{"issue":"15","key":"7898_CR9","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.neuron.2022.05.009","volume":"110","author":"N Panicker","year":"2022","unstructured":"Panicker N, Kam T, Wang H, et al. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson\u2019s disease. Neuron. 2022;110(15):2422\u201337.","journal-title":"Neuron"},{"issue":"9","key":"7898_CR10","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.3390\/biom15091344","volume":"15","author":"I Wo\u017any-Rasa\u0142a","year":"2025","unstructured":"Wo\u017any-Rasa\u0142a I, Og\u0142odek E A. NLRP3 inflammasome in stress-related neuropsychiatric disorders: mechanisms of neuron-microglia-astrocyte crosstalk, HPA axis dysregulation, and therapeutic perspective. Biomolecules. 2025;15(9):1344.","journal-title":"Biomolecules"},{"key":"7898_CR11","doi-asserted-by":"crossref","first-page":"102904","DOI":"10.1016\/j.jaut.2022.102904","volume":"133","author":"X Li","year":"2022","unstructured":"Li X, Zhang Y, Wang J, et al. zVAD alleviates experimental autoimmune hepatitis in mice by increasing the sensitivity of macrophage to TNFR1-dependent necroptosis. J Autoimmun. 2022;133:102904.","journal-title":"J Autoimmun"},{"issue":"1","key":"7898_CR12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41420-023-01647-z","volume":"9","author":"L Wu","year":"2023","unstructured":"Wu L, Zhao H, Zhang M, et al. Regulated cell death and inflammasome activation in gut injury following traumatic surgery in vitro and in vivo: implication for postoperative death due to multiorgan dysfunction. Cell Death Discov. 2023;9(1):409.","journal-title":"Cell Death Discov"},{"issue":"5","key":"7898_CR13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41423-021-00670-3","volume":"18","author":"S Paik","year":"2021","unstructured":"Paik S, Kim J K, Silwal P, et al. An update on the regulatory mechanisms of NLRP3 inflammasome activation. Cell Mol Immunol. 2021;18(5):1141\u201360.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"7898_CR14","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1038\/s41598-020-59408-2","volume":"10","author":"W Wang","year":"2020","unstructured":"Wang W, Zhao H, Chen B. DJ-1 protects retinal pericytes against high glucose-induced oxidative stress through the Nrf2 signaling pathway. Sci Rep. 2020;10(1):2477.","journal-title":"Sci Rep"},{"issue":"14","key":"7898_CR15","doi-asserted-by":"crossref","first-page":"18879","DOI":"10.18632\/aging.203340","volume":"13","author":"B Wang","year":"2021","unstructured":"Wang B, Li J, Jiao J, et al. Myeloid DJ-1 deficiency protects acetaminophen-induced acute liver injury through decreasing inflammatory response. Aging (Albany NY). 2021;13(14):18879\u201393.","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"7898_CR16","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1111\/febs.16346","volume":"289","author":"D Sakthivel","year":"2022","unstructured":"Sakthivel D, Bolivar B E, Bouchier-Hayes L. Cellular autophagy, an unbidden effect of caspase inhibition by zVAD-fmk. The FEBS J. 2022;289(11):3097\u2013100.","journal-title":"The FEBS J"},{"key":"7898_CR17","doi-asserted-by":"crossref","unstructured":"Yuan B, Kikuchi H, Li J, et al. Cytotoxic effects of darinaparsin, a novel organic arsenical, against human leukemia cells. Int J Mol Sci. 2023;24(3).","DOI":"10.3390\/ijms24032282"},{"issue":"2","key":"7898_CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1124\/jpet.123.001820","volume":"388","author":"EJ Shah","year":"2024","unstructured":"Shah EJ, Grunwald WJ, Garrett TL, et al. Sarin-induced neuroinflammation in mouse brain is attenuated by the caspase inhibitor Q-VD-OPh. J Pharmacol Exp Ther. 2024;388(2):367\u201375.","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"7898_CR19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41419-023-06237-6","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhang J, Zhao Y, et al. ChemR23 activation attenuates cognitive impairment in chronic cerebral hypoperfusion by inhibiting NLRP3 inflammasome-induced neuronal pyroptosis. Cell Death Dis. 2023;14(11):721.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7898_CR20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s11658-021-00294-5","volume":"26","author":"S Deng","year":"2021","unstructured":"Deng S, Wu D, Li L, et al. TBHQ attenuates ferroptosis against 5-fluorouracil-induced intestinal epithelial cell injury and intestinal mucositis via activation of Nrf2. Cell Mol Biol Lett. 2021;26(1):48.","journal-title":"Cell Mol Biol Lett"},{"key":"7898_CR21","doi-asserted-by":"crossref","unstructured":"Ngo V, Brickenden A, Liu H, et al. A novel yeast model detects Nrf2 and Keap1 interactions with Hsp90. Dis Model Mech. 2022;15(4).","DOI":"10.1242\/dmm.049258"},{"issue":"22","key":"7898_CR22","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1016\/j.molcel.2021.09.015","volume":"81","author":"J Li","year":"2021","unstructured":"Li J, Cai Z, Vaites L P, et al. Proteome-wide mapping of short-lived proteins in human cells. Mol Cell. 2021;81(22):4722\u201335.","journal-title":"Mol Cell"},{"issue":"11","key":"7898_CR23","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S1474-4422(19)30078-X","volume":"18","author":"K Shi","year":"2019","unstructured":"Shi K, Tian D C, Li Z G, et al. Global brain inflammation in stroke. The Lancet Neurol. 2019;18(11):1058\u201366.","journal-title":"The Lancet Neurol"},{"issue":"5","key":"7898_CR24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/1747493020975229","volume":"16","author":"CM Ermine","year":"2021","unstructured":"Ermine CM, Bivard A, Parsons M W, et al. The ischemic penumbra: from concept to reality. Int J Stroke. 2021;16(5):497\u2013509.","journal-title":"Int J Stroke"},{"issue":"5","key":"7898_CR25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2024;25(5):379\u201395.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"7898_CR26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41418-020-00722-7","volume":"28","author":"Y Meng","year":"2021","unstructured":"Meng Y, Sandow J J, Czabotar P E, et al. The regulation of necroptosis by post-translational modifications. Cell Death Differ. 2021;28(3):861\u201383.","journal-title":"Cell Death Differ"},{"issue":"7","key":"7898_CR27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41419-020-02770-w","volume":"11","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li M, Li X, et al. Catalytically inactive RIP1 and RIP3 deficiency protect against acute ischemic stroke by inhibiting necroptosis and neuroinflammation. Cell Death Dis. 2020;11(7):565.","journal-title":"Cell Death Dis"},{"issue":"4","key":"7898_CR28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.14336\/AD.2018.0728","volume":"10","author":"XX Deng","year":"2019","unstructured":"Deng XX, Li SS, Sun F Y. Necrostatin-1 prevents necroptosis in brains after ischemic stroke via inhibition of RIPK1-mediated RIPK3\/MLKL signaling. Aging Dis. 2019;10(4):807\u201317.","journal-title":"Aging Dis"},{"issue":"3","key":"7898_CR29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","volume":"75","author":"Q Ma","year":"2023","unstructured":"Ma Q. Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction. Pharmacol Rev. 2023;75(3):487\u2013520.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"7898_CR30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12974-025-03492-6","volume":"22","author":"M Zhang","year":"2025","unstructured":"Zhang M, Guo B, Zhang X, et al. IFP35, a novel DAMP, aggravates neuroinflammation following acute ischemic stroke via TLR4\/NF-\u03baB\/NLRP3 signaling. J Neuroinflammation. 2025;22(1):164.","journal-title":"J Neuroinflammation"},{"issue":"9","key":"7898_CR31","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114\u201327.","journal-title":"Cell Mol Immunol"},{"key":"7898_CR32","doi-asserted-by":"crossref","unstructured":"Fann DY, Lee SY, Manzanero S, et al. Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis. 2013;4:e790.","DOI":"10.1038\/cddis.2013.326"},{"key":"7898_CR33","doi-asserted-by":"crossref","first-page":"110287","DOI":"10.1016\/j.intimp.2023.110287","volume":"120","author":"M Fan","year":"2023","unstructured":"Fan M, Wang C, Zhao X, et al. Parthenolide alleviates microglia-mediated neuroinflammation via MAPK\/TRIM31\/NLRP3 signaling to ameliorate cognitive disorder. Int Immunopharmacol. 2023;120:110287.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"7898_CR34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s12035-017-0394-9","volume":"55","author":"DY Fann","year":"2018","unstructured":"Fann DY, Lim YA, Cheng YL, et al. Evidence that NF-kappaB and MAPK signaling promotes NLRP inflammasome activation in neurons following ischemic stroke. Mol Neurobiol. 2018;55(2):1082\u201396.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"7898_CR35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1006\/bbrc.1997.6132","volume":"231","author":"D Nagakubo","year":"1997","unstructured":"Nagakubo D, Taira T, Kitaura H, et al. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. Biochem Biophys Res Commun. 1997;231(2):509\u201313.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"7898_CR36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12974-024-03164-x","volume":"21","author":"F Lind-Holm M","year":"2024","unstructured":"Lind-Holm M F, Sousa C, Ameli C, et al. PARK7\/DJ-1 deficiency impairs microglial activation in response to LPS-induced inflammation. J Neuroinflammation. 2024;21(1):174.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"7898_CR37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1750-1326-6-48","volume":"6","author":"Y Kitamura","year":"2011","unstructured":"Kitamura Y, Watanabe S, Taguchi M, et al. Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson\u2019s disease and stroke model rats. Mol Neurodegener. 2011;6(1):48.","journal-title":"Mol Neurodegener"},{"key":"7898_CR38","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2019.07.007","volume":"49","author":"CJ Lee","year":"2019","unstructured":"Lee CJ, Wu CC, Chou WJ, et al. Mitochondrial-associated protein biomarkers in patients with attention-deficit\/hyperactivity disorder. Mitochondrion. 2019;49:83\u201388.","journal-title":"Mitochondrion"},{"issue":"3","key":"7898_CR39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10863-019-09798-4","volume":"51","author":"LP Dolgacheva","year":"2019","unstructured":"Dolgacheva LP, Berezhnov AV, Fedotova EI, et al. Role of DJ-1 in the mechanism of pathogenesis of Parkinson\u2019s disease. J Bioenerg Biomembr. 2019;51(3):175\u201388.","journal-title":"J Bioenerg Biomembr"},{"issue":"12","key":"7898_CR40","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1007\/s00417-023-06099-w","volume":"261","author":"L Ouyang","year":"2023","unstructured":"Ouyang L, He T, Xing Y. Park7 protects retinal ganglion cells and promotes functional preservation after optic nerve crush via regulation of the Nrf2 signaling pathway. Graefes Arch Clin Exp Ophthalmol. 2023;261(12):3489\u2013502.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7898_CR41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.freeradbiomed.2021.12.001","volume":"179","author":"M Chen Q","year":"2022","unstructured":"Chen Q M. Nrf2 for protection against oxidant generation and mitochondrial damage in cardiac injury. Free Radic Biol Med. 2022;179:133\u201343.","journal-title":"Free Radic Biol Med"},{"key":"7898_CR42","doi-asserted-by":"crossref","unstructured":"He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond. Int J Mol Sci. 2020;21(13).","DOI":"10.3390\/ijms21134777"},{"key":"7898_CR43","doi-asserted-by":"crossref","first-page":"112515","DOI":"10.1016\/j.intimp.2024.112515","volume":"138","author":"D Wu","year":"2024","unstructured":"Wu D, Xu J, Zhang Y, et al. tBHQ mitigates fatty liver ischemia-reperfusion injury by activating Nrf2 to attenuate hepatocyte mitochondrial damage and macrophage STING activation. Int Immunopharmacol. 2024;138:112515.","journal-title":"Int Immunopharmacol"},{"key":"7898_CR44","doi-asserted-by":"crossref","first-page":"6635460","DOI":"10.1155\/2021\/6635460","volume":"2021","author":"C Yu","year":"2021","unstructured":"Yu C, Xiao J H. The Keap1-Nrf2 system: a mediator between oxidative stress and aging. Oxid Med Cell Longev. 2021;2021:6635460.","journal-title":"Oxid Med Cell Longev"},{"key":"7898_CR45","doi-asserted-by":"crossref","first-page":"102389","DOI":"10.1016\/j.redox.2022.102389","volume":"54","author":"S Liu","year":"2022","unstructured":"Liu S, Pi J, Zhang Q. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway. Redox Biol. 2022;54:102389.","journal-title":"Redox Biol"},{"issue":"1","key":"7898_CR46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12974-023-02776-z","volume":"20","author":"F Lind-Holm M","year":"2023","unstructured":"Lind-Holm M F, Scafidi A, Poli A, et al. PARK7\/DJ-1 in microglia: implications in Parkinson\u2019s disease and relevance as a therapeutic target. J Neuroinflammation. 2023;20(1):95.","journal-title":"J Neuroinflammation"},{"key":"7898_CR47","doi-asserted-by":"crossref","first-page":"737065","DOI":"10.3389\/fimmu.2021.737065","volume":"12","author":"B Tastan","year":"2021","unstructured":"Tastan B, Arioz B I, Tufekci K U, et al. Dimethyl fumarate alleviates NLRP3 inflammasome activation in microglia and sickness behavior in LPS-challenged mice. Front Immunol. 2021;12:737065.","journal-title":"Front Immunol"},{"issue":"1","key":"7898_CR48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12974-016-0733-1","volume":"13","author":"R Lin","year":"2016","unstructured":"Lin R, Cai J, Kostuk E W, et al. Fumarate modulates the immune\/inflammatory response and rescues nerve cells and neurological function after stroke in rats. J Neuroinflammation. 2016;13(1):269.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"7898_CR49","first-page":"679","volume":"41","author":"L Li","year":"2021","unstructured":"Li L, Peng L, Zhu J, et al. DJ-1 alleviates oxidative stress injury by activating the Nrf2 pathway in rats with cerebral ischemia-reperfusion injury. Nan Fang Yi Ke Da Xue Xue Bao. 2021;41(5):679\u201386.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07898-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:49:51Z","timestamp":1781635791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07898-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7898"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07898-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures involving animals were conducted in accordance with the guidelines and regulations for the care and use of laboratory animals, and were approved by the Institutional Animal Care and Use Committee (IACUC) of Experimental Animal Ethics Committee of Xuzhou Medical University (Approval No. 202212S007). Efforts were made to minimize the number of animals used and to reduce their suffering. Animals were housed in a controlled environment with free access to food and water, and all procedures were performed under appropriate anesthesia and analgesia to ensure humane treatment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not deal with relevant human experiments, and the Ethics Statement for Animal Experiments has been adopted. Articles are published with the consent of all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"445"}}